Prospera Monetary Providers Inc decreased its place in Cencora, Inc. (NYSE:COR – Free Report) by 1.3% within the third quarter, Holdings Channel reviews. The agency owned 9,875 shares of the corporate’s inventory after promoting 131 shares throughout the interval. Prospera Monetary Providers Inc’s holdings in Cencora had been value $2,223,000 on the finish of the latest quarter.
A variety of different giant traders additionally not too long ago purchased and offered shares of COR. Osaic Holdings Inc. purchased a brand new place in Cencora within the first quarter value roughly $9,962,000. Covestor Ltd purchased a brand new place in Cencora within the first quarter value roughly $55,000. Ameritas Funding Companions Inc. purchased a brand new place in Cencora within the first quarter value roughly $465,000. American Worldwide Group Inc. purchased a brand new place in Cencora within the first quarter value roughly $10,872,000. Lastly, InterOcean Capital Group LLC purchased a brand new place in Cencora within the first quarter value roughly $251,000. Institutional traders personal 97.52% of the corporate’s inventory.
Analysts Set New Value Targets
A variety of equities analysts not too long ago commented on COR shares. Wells Fargo & Firm boosted their worth goal on shares of Cencora from $236.00 to $249.00 and gave the inventory an “equal weight” ranking in a analysis notice on Thursday, August 1st. Leerink Companions decreased their worth goal on Cencora from $277.00 to $275.00 and set an “outperform” ranking on the inventory in a analysis report on Monday, October seventh. Financial institution of America reaffirmed a “impartial” ranking and set a $245.00 worth goal (down from $275.00) on shares of Cencora in a analysis report on Wednesday, September 18th. StockNews.com downgraded Cencora from a “strong-buy” ranking to a “purchase” ranking in a analysis report on Friday, September twentieth. Lastly, Evercore ISI upped their worth goal on Cencora from $250.00 to $285.00 and gave the inventory an “outperform” ranking in a analysis report on Thursday, November seventh. Three analysts have rated the inventory with a maintain ranking and 9 have given a purchase ranking to the inventory. In line with knowledge from MarketBeat, the inventory presently has a consensus ranking of “Reasonable Purchase” and a mean goal worth of $271.20.
View Our Newest Inventory Evaluation on COR
Cencora Buying and selling Up 0.9 %
COR inventory opened at $243.20 on Thursday. The corporate’s 50-day easy transferring common is $232.82 and its 200-day easy transferring common is $231.29. The corporate has a fast ratio of 0.53, a present ratio of 0.88 and a debt-to-equity ratio of 4.84. Cencora, Inc. has a 52-week low of $195.83 and a 52-week excessive of $251.56. The agency has a market cap of $47.92 billion, a P/E ratio of 32.38, a PEG ratio of 1.60 and a beta of 0.44.
Cencora Will increase Dividend
The enterprise additionally not too long ago declared a quarterly dividend, which will probably be paid on Friday, November twenty ninth. Traders of file on Friday, November fifteenth will probably be given a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a dividend yield of 0.90%. The ex-dividend date is Friday, November fifteenth. This is a rise from Cencora’s earlier quarterly dividend of $0.51. Cencora’s dividend payout ratio is 29.29%.
Insider Shopping for and Promoting
In different Cencora information, Chairman Steven H. Collis offered 21,509 shares of the inventory in a transaction dated Tuesday, October twenty second. The shares had been offered at a mean worth of $235.80, for a complete worth of $5,071,822.20. Following the completion of the sale, the chairman now owns 285,088 shares within the firm, valued at roughly $67,223,750.40. This represents a 7.02 % lower of their place. The transaction was disclosed in a authorized submitting with the Securities & Alternate Fee, which is accessible by means of the SEC web site. Insiders personal 15.80% of the corporate’s inventory.
Cencora Firm Profile
Cencora, Inc sources and distributes pharmaceutical merchandise. The corporate’s U.S. Healthcare Options phase distributes prescription drugs, over-the-counter healthcare merchandise, residence healthcare provides and gear, and associated providers to acute care hospitals and well being programs, unbiased and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate web site pharmacies, and different clients; supplies pharmacy administration, staffing, and different consulting providers; provide administration software program to retail and institutional healthcare suppliers; packaging options to numerous institutional and retail healthcare suppliers; medical trial assist, product post-approval, and commercialization assist providers; knowledge analytics, outcomes analysis, and extra providers for biotechnology and pharmaceutical producers; prescription drugs, vaccines, parasiticides, diagnostics, micro feed components, and different merchandise to the companion animal and manufacturing animal markets; and gross sales pressure providers to producers.
Additional Studying
Wish to see what different hedge funds are holding COR? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for Cencora, Inc. (NYSE:COR – Free Report).
Obtain Information & Scores for Cencora Each day – Enter your electronic mail deal with beneath to obtain a concise day by day abstract of the most recent information and analysts’ rankings for Cencora and associated firms with MarketBeat.com’s FREE day by day electronic mail publication.
